S&P Futures
5,883.25 -13.00 (-0.22%) Dow Futures
43,098.00 -79.00 (-0.18%) Nasdaq Futures
20,453.50 -66.00 (-0.32%) Russell 2000 Futures
2,247.30 -8.20 (-0.36%) Crude Oil
70.50 -0.06 (-0.09%) Gold
2,750.90 +12.00 (+0.44%)
Terns Pharmaceuticals Inc (430.F)
| Previous Close | 6.65 |
| Open | 6.55 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's Range | 6.55 - 6.55 |
| 52 Week Range | 3.04 - 10.20 |
| Volume | |
| Avg. Volume | 17 |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | Nov 12, 2024 - Nov 18, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
GlobeNewswireTerns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)
FOSTER CITY, Calif., Oct. 07, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity, today announced that it has granted as of October 1, 2024 an equity inducement award to a new employee under the terms of the 2022 Employment Inducement Award Plan, as amended (the “Inducement Plan”). The equit
TipRanksInsiders Snap Up These 2 ‘Strong Buy’ Stocks
Let’s talk about insider trading. Not the illegal kind, but the perfectly normal – and fully legal – trading by top-level corporate officers. These are the C-suite residents and the members of the Boards, company officers who know what’s going on behind the scenes and are responsible to shareholders for bringing in profits. They typically hold shares in their own companies and make trades based on the knowledge they have from behind the scenes. To keep the playing field level, federal regulators
